Impact of probiotic supplements on microbiome diversity following antibiotic treatment of mice

Gut Microbes

Volumn 7, Issue 2, 2016, Pages 101-114

  Grazul, Hannah ^a   Kanda, L Leann ^a   Gondek, David ^a  

^a ITHACA COLLEGE   (United States)

Author keywords

16S rRNA; anaerotruncus; antibiotic; microbiome; probiotic; sequencing

Indexed keywords

AMPICILLIN; CLINDAMYCIN; PROBIOTIC AGENT; RNA 16S; STREPTOMYCIN; ANTIINFECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GROWTH; BACTEROIDALES; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM LONGUM; CONTROLLED STUDY; DIET SUPPLEMENTATION; DNA EXTRACTION; ESCHERICHIA; FIRMICUTES; GENE SEQUENCE; INTESTINE FLORA; LACHNOSPIRACEAE; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS RHAMNOSUS; MICROBIAL DIVERSITY; MICROBIOME; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; SHIGELLA; STENOTROPHOMONAS; XANTHOMONAS; ANALYSIS; ANIMAL; BACTERIUM; BIODIVERSITY; C57BL MOUSE; CLASSIFICATION; DIARRHEA; DIETARY SUPPLEMENT; DRUG EFFECTS; FEMALE; GASTROINTESTINAL TRACT; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BIODIVERSITY; DIARRHEA; DIETARY SUPPLEMENTS; FEMALE; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; MALE; MICE; MICE, INBRED C57BL; PROBIOTICS;

EID: 84961214408     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.1080/19490976.2016.1138197     Document Type: Article

References (59)

1. L.Krych, C.H.F.Hansen, A.K.Hansen, F.W.J.van den Berg, D.S.Nielsen. Quantitatively different, yet qualitatively alike: a meta-analysis of the mouse core gut microbiome with a view towards the human gut microbiome. PLoS One 2013; 8(5):e62578; PMID:23658749; http://dx.doi.org/10.1371/journal.pone.0062578
2. C.A.Lozupone, J.I.Stombaugh, J.I.Gordon, J.K.Jansson, R.Knight. Diversity, stability and resilience of the human gut microbiota. Nature 2012; 489(7415):220-30; PMID:22972295; http://dx.doi.org/10.1038/nature11550
3. J.Tap, S.Mondot, F.Levenez, E.Pelletier, C.Caron, J.P.Furet, E.Ugarte, R.Muñoz-Tamayo, D.L.Paslier, R.Nalin, et al. Towards the human intestinal microbiota phylogenetic core. Environ Microbiol 2009; 11(10):2574-84; PMID:19601958; http://dx.doi.org/10.1111/j.1462-2920.2009.01982.x
4. L.V.Hooper. Bacterial contributions to mammalian gut development. Trends Microbiol 2004; 12(3):129-34; PMID:15001189; http://dx.doi.org/10.1016/j.tim.2004.01.001
5. E.S.Lamousé-Smith, A.Tzeng, M.N.Starnbach. The intestinal flora is required to support antibody responses to systemic immunization in infant and germ free mice. PLoS One 2011; 6(11):e27662; PMID:Can't; http://dx.doi.org/10.1371/journal.pone.0027662
6. M.Li, B.Wang, M.Zhang, M.Rantalainen, S.Wang, H.Zhou, Y.Zhang, J.Shen, X.Pang, M.Zhang, et al. Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci U S A 2008; 105(6):2117-22; PMID:18252821; http://dx.doi.org/10.1073/pnas.0712038105
7. I.Sekirov, N.M.Tam, M.Jogova, M.L.Robertson, Y.Li, C.Lupp, B.B.Finlay. Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infect Immun 2008; 76(10):4726-36; PMID:18678663; http://dx.doi.org/10.1128/IAI.00319-08
8. K.A.Knoop, K.G.McDonald, D.H.Kulkarni, R.D.Newberry. Antibiotics promote inflammation through the translocation of native commensal colonic bacteria. Gut 2015; Jun 4:pii PMID:26045138; http://dx.doi.org/10.1136/gutjnl-2014-309059
9. R.E.Ley, P.J.Turnbaugh, S.Klein, J.I.Gordon. Microbial ecology: human gut microbes associated with obesity. Nature 2006; 444(7122):1022-3; PMID:17183309; http://dx.doi.org/10.1038/4441022a
10. L.Jostins, S.Ripke, R.K.Weersma, R.H.Duerr, D.P.McGovern, K.Y.Hui, J.C.Lee, L.P.Schumm, Y.Sharma, C.A.Anderson, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012; 491(7422):119-24; PMID:23128233; http://dx.doi.org/10.1038/nature11582
11. C.Jernberg, S.Löfmark, C.Edlund, J.K.Jansson. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J 2007; 1(1):56-66; PMID:18043614; http://dx.doi.org/10.1038/ismej.2007.3
12. A.A.Salyers, A.Gupta, Y.Wang. Human intestinal bacteria as reservoirs for antibiotic resistance genes. Trends Microbiol 2004; 12(9):412-6; PMID:15337162; http://dx.doi.org/10.1016/j.tim.2004.07.004
13. N.P.McNulty, T.Yatsunenko, A.Hsiao, J.J.Faith, B.D.Muegge, A.L.Goodman, B.Henrissat, R.Oozeer, S.Cools-Portier, G.Gobert, et al. The Impact of a Consortium of Fermented Milk Strains on the Gut Microbiome of Gnotobiotic Mice and Monozygotic Twins. Sci Transl Med 2011; 3(106):106ra106-106ra106; PMID:22030749; http://dx.doi.org/10.1126/scitranslmed.3002701
14. T.D.Lawley, S.Clare, A.W.Walker, M.D.Stares, T.R.Connor, C.Raisen, D.Goulding, R.Rad, F.Schreiber, C.Brandt, et al. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog 2012; 8(10):e1002995; PMID:23133377; http://dx.doi.org/10.1371/journal.ppat.1002995
15. S.Hempel, S.J.Newberry, A.R.Maher, Z.Wang, J.N.Miles, R.Shanman, B.Johnsen, P.G.Shekelle. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 2012; 307(18):1959-69; PMID:22570464; http://dx.doi.org/10.1001/jama.2012.3507
16. J.Gerritsen, H.Smidt, G.T.Rijkers, W.M.de Vos. Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr 2011; 6(3):209-40; PMID:21617937; http://dx.doi.org/10.1007/s12263-011-0229-7
17. C.Jernberg, S.Löfmark, C.Edlund, J.K.Jansson. Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology 2010; 156(Pt 11):3216-23; PMID:20705661; http://dx.doi.org/10.1099/mic.0.040618-0
18. P.H.Janssen, P.S.Yates, B.E.Grinton, P.M.Taylor, M.Sait. Improved culturability of soil bacteria and isolation in pure culture of novel members of the divisions Acidobacteria, Actinobacteria, Proteobacteria, and Verrucomicrobia. Appl Environ Microbiol 2002; 68(5):2391-6; PMID:11976113; http://dx.doi.org/10.1128/AEM.68.5.2391-2396.2002
19. J.G.Caporaso, C.L.Lauber, W.A.Walters, D.Berg-Lyons, C.A.Lozupone, P.J.Turnbaugh, N.Fierer, R.Knight. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc Natl Acad Sci U S A 2011; 108 Suppl:4516-22; PMID:20534432; http://dx.doi.org/10.1073/pnas.1000080107
20. J.G.Caporaso, J.Kuczynski, J.Stombaugh, K.Bittinger, F.D.Bushman, E.K.Costello, N.Fierer, A.G.Peña, J.K.Goodrich, J.I.Gordon, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 2010; 7(5):335-6; PMID:20383131; http://dx.doi.org/10.1038/nmeth.f.303
21. T.Matsuki, K.Watanabe, J.Fujimoto, Y.Kado, T.Takada, K.Matsumoto, R.Tanaka. Quantitative PCR with 16S rRNA-gene-targeted species-specific primers for analysis of human intestinal bifidobacteria. Appl Environ Microbiol 2004; 70(1):167-73; PMID:14711639; http://dx.doi.org/10.1128/AEM.70.1.167-173.2004
22. R.Byun, M.A.Nadkarni, K.-L.Chhour, F.E.Martin, N.A.Jacques, N.Hunter. Quantitative analysis of diverse Lactobacillus species present in advanced dental caries. J Clin Microbiol 2004; 42(7):3128-36; PMID:15243071; http://dx.doi.org/10.1128/JCM.42.7.3128-3136.2004
23. T.Bacchetti De Gregoris, N.Aldred, A.S.Clare, J.G.Burgess. Improvement of phylum- and class-specific primers for real-time PCR quantification of bacterial taxa. J Microbiol Methods 2011; 86(3):351-6; PMID:21704084; http://dx.doi.org/10.1016/j.mimet.2011.06.010
24. P.S.La Rosa, J.P.Brooks, E.Deych, E.L.Boone, D.J.Edwards, Q.Wang, E.Sodergren, G.Weinstock, W.D.Shannon. Hypothesis testing and power calculations for taxonomic-based human microbiome data. PLoS One 2012; 7(12):e52078; PMID:23284876; http://dx.doi.org/10.1371/journal.pone.0052078
25. A.M.Schubert, H.Sinani, P.D.Schloss. Antibiotic-induced alterations of the murine gut microbiota and subsequent effects on colonization resistance against clostridium difficile. MBio 2015; 6(4):e00974; PMID:26173701; http://dx.doi.org/10.1128/mBio.00974-15
26. C.G.Buffie, E.G.Pamer. Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol 2013; 13(11):790-801; PMID:24096337; http://dx.doi.org/10.1038/nri3535
27. C.G.Buffie, I.Jarchum, M.Equinda, L.Lipuma, A.Gobourne, A.Viale, C.Ubeda, J.Xavier, E.G.Pamer. Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis. Infect Immun 2012; 80(1):62-73; PMID:22006564; http://dx.doi.org/10.1128/IAI.05496-11
28. D.A.Antonopoulos, S.M.Huse, H.G.Morrison, T.M.Schmidt, M.L.Sogin, V.B.Young. Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect Immun 2009; 77(6):2367-75; PMID:19307217; http://dx.doi.org/10.1128/IAI.01520-08
29. G.Huys, M.Vancanneyt, K.D'Haene, V.Vankerckhoven, H.Goossens, J.Swings. Accuracy of species identity of commercial bacterial cultures intended for probiotic or nutritional use. Res Microbiol 2006; 157(9):803-10; PMID:16919915; http://dx.doi.org/10.1016/j.resmic.2006.06.006
30. L.Masco, G.Huys, E.De Brandt, R.Temmerman, J.Swings. Culture-dependent and culture-independent qualitative analysis of probiotic products claimed to contain bifidobacteria. Int J Food Microbiol 2005; 102(2):221-30; PMID:15992621; http://dx.doi.org/10.1016/j.ijfoodmicro.2004.11.018
31. C.De Filippo, D.Cavalieri, M.Di Paola, M.Ramazzotti, J.B.Poullet, S.Massart, S.Collini, G.Pieraccini, P.Lionetti. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A 2010; 107(33):14691-6; PMID:20679230; http://dx.doi.org/10.1073/pnas.1005963107
32. H.Chung, S.J.Pamp, J.A.Hill, N.K.Surana, S.M.Edelman, E.B.Troy, N.C.Reading, E.J.Villablanca, S.Wang, J.R.Mora, et al. Gut immune maturation depends on colonization with a host-specific microbiota. Cell 2012; 149(7):1578-93; PMID:22726443; http://dx.doi.org/10.1016/j.cell.2012.04.037
33. A.L.Goodman, G.Kallstrom, J.J.Faith, A.Reyes, A.Moore, G.Dantas, J.I.Gordon. Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice. Proc Natl Acad Sci U S A 2011; 108(15):6252-7; PMID:21436049; http://dx.doi.org/10.1073/pnas.1102938108
34. P.J.Turnbaugh, M.Hamady, T.Yatsunenko, B.L.Cantarel, A.Duncan, R.E.Ley, M.L.Sogin, W.J.Jones, B.A.Roe, J.P.Affourtit, et al. A core gut microbiome in obese and lean twins. Nature 2009; 457(7228):480-4; PMID:19043404; http://dx.doi.org/10.1038/nature07540
35. V.K.Ridaura, J.J.Faith, F.E.Rey, J.Cheng, A.E.Duncan, A.L.Kau, N.W.Griffin, V.Lombard, B.Henrissat, J.R.Bain, et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 2013; 341(6150):1241214; PMID:24009397; http://dx.doi.org/10.1126/science.1241214
36. A.Shreiner, G.B.Huffnagle, M.C.Noverr. The “Microflora Hypothesis” of allergic disease. Adv Exp Med Biol 2008; 635:113-4; PMID:18841708; http://dx.doi.org/10.1007/978-0-387-09550-9_10
37. M.J.Koenigsknecht, C.M.Theriot, I.L.Bergin, C.A.Schumacher, P.D.Schloss, V.B.Young. Dynamics and establishment of Clostridium difficile infection in the murine gastrointestinal tract. Infect Immun 2015; 83(3):934-41; PMID:25534943; http://dx.doi.org/10.1128/IAI.02768-14
38. L.K.Ursell, W.Van Treuren, J.L.Metcalf, M.Pirrung, A.Gewirtz, R.Knight. Replenishing our defensive microbes. Bioessays 2013; 35(9):810-7; PMID:23836415; http://dx.doi.org/10.1002/bies.201300018
39. E.Van Nood, A.Vrieze, M.Nieuwdorp, S.Fuentes, E.G.Zoetendal, W.M.de Vos, C.E.Visser, E.J.Kuijper, J.F.Bartelsman, J.G.Tijssen, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013; 368(5):407-15; PMID:23323867; http://dx.doi.org/10.1056/NEJMoa1205037
40. L.V.McFarland. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol 2006; 101(4):812-22; PMID:16635227; http://dx.doi.org/10.1111/j.1572-0241.2006.00465.x
41. M.Alander, R.Satokari, R.Korpela, M.Saxelin, T.Vilpponen-Salmela, T.Mattila-Sandholm, A.von Wright. Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption. Appl Environ Microbiol 1999; 65(1):351-4; PMID:9872808
42. Y.K.Lee, P.S.Ho, C.S.Low, H.Arvilommi, S.Salminen. Permanent colonization by Lactobacillus casei is hindered by the low rate of cell division in mouse gut. Appl Environ Microbiol 2004; 70(2):670-4; PMID:14766540; http://dx.doi.org/10.1128/AEM.70.2.670-674.2004
43. E.A.Eloe-Fadrosh, A.Brady, J.Crabtree, E.F.Drabek, B.Ma, A.Mahurkar, J.Ravel, M.Haverkamp, A.M.Fiorino, C.Botelho, et al. Functional dynamics of the gut microbiome in elderly people during probiotic consumption. MBio 2015; 6(2):pii: e00231-15; PMID:25873374; http://dx.doi.org/10.1128/mBio.00231-15
44. L.Lahti, A.Salonen, R.A.Kekkonen, J.Salojärvi, J.Jalanka-Tuovinen, A.Palva, M.Orešič, W.M.de Vos. Associations between the human intestinal microbiota, Lactobacillus rhamnosus GG and serum lipids indicated by integrated analysis of high-throughput profiling data. PeerJ 2013; 1:e32; PMID:23638368; http://dx.doi.org/10.7717/peerj.32
45. V.Venugopalan, K.A.Shriner, A.Wong-Beringer. Regulatory oversight and safety of probiotic use. Emerg Infect Dis 2010; 16(11):1661-5; PMID:21029521; http://dx.doi.org/10.3201/eid1611.100574
46. M.E.Sanders, L.M.A.Akkermans, D.Haller, C.Hammerman, J.Heimbach, G.Hörmannsperger, G.Huys, D.D.Levy, F.Lutgendorff, D.Mack, et al. Safety assessment of probiotics for human use. Gut Microbes 1(3):164-85; PMID:21327023; http://dx.doi.org/10.4161/gmic.1.3.12127
47. M.H.Land, K.Rouster-Stevens, C.R.Woods, M.L.Cannon, J.Cnota, A.K.Shetty. Lactobacillus sepsis associated with probiotic therapy. Pediatrics 2005; 115(1):178-81; PMID:15629999
48. M.Rautio, H.Jousimies-Somer, H.Kauma, I.Pietarinen, M.Saxelin, S.Tynkkynen, M.Koskela. Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG. Clin Infect Dis 1999; 28(5):1159-60; PMID:10452653; http://dx.doi.org/10.1086/514766
49. C.D.Doern, S.T.Nguyen, F.Afolabi, C.-A.D.Burnham. Probiotic-associated aspiration pneumonia due to Lactobacillus rhamnosus. J Clin Microbiol 2014; 52(8):3124-6; PMID:24899028; http://dx.doi.org/10.1128/JCM.01065-14
50. J.S.Brooke. Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen. Clin Microbiol Rev 2012; 25(1):2-41; PMID:22232370; http://dx.doi.org/10.1128/CMR.00019-11
51. W.J.Looney, M.Narita, K.Mühlemann. Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect Dis 2009; 9(5):312-23; PMID:19393961; http://dx.doi.org/10.1016/S1473-3099(09)70083-0
52. V.Waters, E.G.Atenafu, A.Lu, Y.Yau, E.Tullis, F.Ratjen. Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients. J Cyst Fibros 2013; 12(5):482-6; PMID:23294530; http://dx.doi.org/10.1016/j.jcf.2012.12.006
53. S.K.P.Lau, P.C.Y.Woo, G.K.S.Woo, A.M.Fung, A.H.Ngan, Y.Song, C.Liu, P.Summanen, S.M.Finegold, K.Yuen. Bacteraemia caused by Anaerotruncus colihominis and emended description of the species. J Clin Pathol 2006; 59(7):748-52; PMID:16467163; http://dx.doi.org/10.1136/jcp.2005.031773
54. P.A.Lawson, Y.Song, C.Liu, D.R.Molitoris, M.L.Vaisanen, M.D.Collins, S.M.Finegold. Anaerotruncus colihominis gen. nov., sp. nov., from human faeces. Int J Syst Evol Microbiol 2004; 54(Pt 2):413-7; PMID:15023953; http://dx.doi.org/10.1099/ijs.0.02653-0
55. K.Atarashi, T.Tanoue, K.Oshima, W.Suda, Y.Nagano, H.Nishikawa, S.Fukuda, T.Saito, S.Narushima, K.Hase, et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 2013; 500(7461):232-6; PMID:23842501; http://dx.doi.org/10.1038/nature12331
56. R.Satokari, S.Fuentes, E.Mattila, J.Jalanka, W.M.de Vos, P.Arkkila. Fecal transplantation treatment of antibiotic-induced, noninfectious colitis and long-term microbiota follow-up. Case Rep Med 2014; 2014:913867; PMID:25548572
57. L.Watterlot, T.Rochat, H.Sokol, C.Cherbuy, I.Bouloufa, F.Lefèvre, J.J.Gratadoux, E.Honvo-Hueto, S.Chilmonczyk, S.Blugeon, et al. Intragastric administration of a superoxide dismutase-producing recombinant Lactobacillus casei BL23 strain attenuates DSS colitis in mice. Int J Food Microbiol 2010; 144(1):35-41; PMID:20452077; http://dx.doi.org/10.1016/j.ijfoodmicro.2010.03.037
58. S.A.Ballal, P.Veiga, K.Fenn, M.Michaud, J.H.Kim, C.A.Gallini, J.N.Glickman, G.Quéré, P.Garault, C.Béal, et al. Host lysozyme-mediated lysis of Lactococcus lactis facilitates delivery of colitis-attenuating superoxide dismutase to inflamed colons. Proc Natl Acad Sci U S A 2015; 112(25):7803-8; PMID:26056274; http://dx.doi.org/10.1073/pnas.1501897112
59. P.Veiga, C.A.Gallini, C.Beal, M.Michaud, M.L.Delaney, A.DuBois, A.Khlebnikov, J.E.van Hylckama Vlieg, S.Punit, J.N.Glickman, et al. Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes. Proc Natl Acad Sci U S A 2010; 107(42):18132-7; PMID:20921388; http://dx.doi.org/10.1073/pnas.1011737107